[Treatment of low malignancy non-Hodgkin lymphomas with recombinant interferon. Current status].
Neubauer
A
A
Herrmann
R
R
D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D011994:Recombinant Proteins
D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
Behandlung niedrig-maligner Non-Hodgkin-Lymphome mit rekombinantem Interferon. Derzeitiger Stand.